NUVB stock pitch - 2023-07-12

Added to YB: 2023-07-12

Pitch date: 2023-07-12

Nuvation Bio Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment.

Market Cap

$2.3B

Pitch Price

$1.74

Price Target

N/A

Dividend

N/A

EV/EBITDA

-15.22

P/E

-14.77

EV/Sales

11.95

Sector

Pharmaceuticals

A summary for this pitch has not been created yet.